We are live on
!
Find out more
ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
21 hedge funds and large institutions have $55.4M invested in ZyVersa Therapeutics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
0.2% more ownership
Funds ownership: 0% → 0.2% (+0.2%)
Holders
21
Holders Change
+21
Holders Change %
–
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CM
Cohanzick Management
Pleasantville,
New York
|
+$6.92M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$6.92M |
| 3 |
RA
RiverPark Advisors
New York
|
+$6.92M |
| 4 |
CCM
Context Capital Management
Lajolla,
California
|
+$4.94M |
| 5 |
SCM
Saba Capital Management
New York
|
+$4.69M |
Top Sellers
No sellers this quarter
